

If so, you may have a possible legal case against the manufacturer of the potentially dangerous drug or medical product. Simply fill out the short form below and an experienced legal expert will contact you as soon as possible!
Added May 6th, 2006

The Food and Drugs Administration has issued warnings relating to the increased risk of suicidal tendencies in young adults that are taking the anti-depressant medication, Paxil. A letter has been sent out to doctors by the FDA and by the manufacturer of the drug, GlaxoSmithKline, warning medical professionals of this increased risk.
Both Paxil and Paxil CR, which is a controlled release version of the medication, have had changes made to the labelling to reflect the possible increase in side effects. This is in addition to the letter that has been sent out to provide doctors with information enabling them to make a more informed choice when prescribing for young adults.
A recent study was carried out using 15,000 patients, some of whom were treated with Paxil and others with placebos. The trials resulted in 11 unsuccessful suicide attempts from those taking the drug and just one by a person taking the placebo.
The manufacturer of the drug has been asked to examine data for any possible links between the drug and increased suicidal tendencies in adults by the Food and Drugs Administration.

Risk Of Suicidal... | Printable Version (Opens In New Window)